Cargando…

Long‐term use of proton pump inhibitors and prevalence of disease‐ and drug‐related reasons for gastroprotection—a cross‐sectional population‐based study

PURPOSE: To analyse the prevalence of long‐term use of proton pump inhibitors (PPI) with respect to underlying diseases and drugs, and to find predictors for such treatment when an evident rationale for the PPI treatment is lacking. METHODS: The study cohort consisted of individuals, ≥65 years in 20...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wallerstedt, Susanna M., Fastbom, Johan, Linke, Johannes, Vitols, Sigurd
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2016
Materias:	Original Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5248645/ https://www.ncbi.nlm.nih.gov/pubmed/27859947 http://dx.doi.org/10.1002/pds.4135

Ejemplares similares

Prevalence and initiation of statin therapy in the oldest old—a longitudinal population-based study
por: Sundvall, Helena, et al.
Publicado: (2022)

Proton pump inhibitors and gastroprotection in patients treated with antithrombotic drugs: A cardiologic point of view
por: Abrignani, Maurizio Giuseppe, et al.
Publicado: (2023)

Cost Effectiveness of Gastroprotection with Proton Pump Inhibitors in Older Low-Dose Acetylsalicylic Acid Users in the Netherlands
por: Chau, Sek Hung, et al.
Publicado: (2017)

Association between drug‐specific indicators of prescribing quality and quality of drug treatment: a validation study
por: Wallerstedt, Susanna M., et al.
Publicado: (2015)

Prescription behavior for gastroprotective drugs in new users as a result of communications regarding clopidogrel – proton pump inhibitor interaction
por: Kruik‐Kollöffel, Willemien J., et al.
Publicado: (2016)

Hypomagnesemia Induced by Long-Term Treatment with Proton-Pump Inhibitors
por: Janett, Simone, et al.
Publicado: (2015)

Hypomagnesaemia associated with long-term use of proton pump inhibitors
por: Toh, James Wei Tatt, et al.
Publicado: (2015)

Advantages and Disadvantages of Long-term Proton Pump Inhibitor Use
por: Kinoshita, Yoshikazu, et al.
Publicado: (2018)

Patient-reported adherence to coprescribed proton pump inhibitor gastroprotection in osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis patients using nonsteroidal anti-inflammatory drugs
por: Henriksson, Kenneth, et al.
Publicado: (2014)

Rebamipide as a Potential Alternative Gastroprotective Agent to Proton Pump Inhibitor in Elderly Chronic Nonsteroidal Anti-Inflammatory Drug Users without Risk Factors
por: Lee, Mee Yeon, et al.
Publicado: (2022)

Drug Treatment in Older People before and after the Transition to a Multi-Dose Drug Dispensing System–A Longitudinal Analysis
por: Wallerstedt, Susanna M., et al.
Publicado: (2013)

Adverse Effects Associated with Long-Term Use of Proton Pump Inhibitors
por: Maideen, Naina Mohamed Pakkir
Publicado: (2023)

Is the Diagnostic Trial with Proton Pump Inhibitors Reasonable for School Age Children with Gastroesophageal Reflux Symptoms?
por: Yang, Jaeeun, et al.
Publicado: (2019)

Proton Pumps: Molecular Mechanisms, Inhibitors and Activators of Proton Pumping
por: Siletsky, Sergey A.
Publicado: (2023)

Prevalence of Proton Pump Inhibitor Use Among Patients With Cancer
por: Raoul, Jean-Luc, et al.
Publicado: (2021)

The risks of long-term use of proton pump inhibitors: a critical review
por: Jaynes, Megan, et al.
Publicado: (2018)

Long-term proton pump inhibitor usage and the association with pancreatic cancer in Sweden
por: Brusselaers, Nele, et al.
Publicado: (2019)

Long-Term Use of Proton Pump Inhibitors in Cancer Patients: An Opinion Paper
por: Raoul, Jean-Luc, et al.
Publicado: (2022)

Association between Multi-Dose Drug Dispensing and Quality of Drug Treatment – A Register-Based Study
por: Sjöberg, Christina, et al.
Publicado: (2011)

Proton Pump Inhibitors and Gastritis
por: Suzuki, Masayuki, et al.
Publicado: (2008)

Proton pump inhibitors and gastroenteritis
por: Hassing, Robert-Jan, et al.
Publicado: (2016)

Deprescribing proton pump inhibitors
por: Teh, Kim Jun Kevin, et al.
Publicado: (2023)

Performance of 3 Sets of Criteria for Potentially Inappropriate Prescribing in Older People to Identify Inadequate Drug Treatment
por: Wallerstedt, Susanna M., et al.
Publicado: (2022)

Does long-term use of proton pump inhibitors cause hypomagnesaemia in Japanese outpatients?
por: Takeda, Yasuhito, et al.
Publicado: (2015)

Does Long-Term Proton Pump Inhibitor Therapy Affect the Health of Gut Microbiota?
por: Lee, Chansu, et al.
Publicado: (2016)

Iron Deficiency Anemia Due to the Long-term Use of a Proton Pump Inhibitor
por: Imai, Ryosuke, et al.
Publicado: (2017)

Proton‐Pump Inhibitors and Long‐Term Risk of Community‐Acquired Pneumonia in Older Adults
por: Zirk‐Sadowski, Jan, et al.
Publicado: (2018)

Long-term Proton Pump Inhibitor Administration Caused Physiological and Microbiota Changes in Rats
por: Yang, Yu-Chen S. H., et al.
Publicado: (2020)

Long-Term Usage of Proton Pump Inhibitors Associated with Prognosis in Patients with Colorectal Cancer
por: Wu, Chin-Chia, et al.
Publicado: (2023)

Gastroprotection during long-term dual antiplatelet therapy: to give or not to give?
por: Sbrana, Francesco, et al.
Publicado: (2021)

Pharmacokinetics and Pharmacodynamics of the Proton Pump Inhibitors
por: Shin, Jai Moo, et al.
Publicado: (2013)

Proton pump inhibitors and hypomagnesemia monitoring
por: Lemon, Thomas I
Publicado: (2013)

Use and overuse of proton pump inhibitors
por: Staiano, Annamaria, et al.
Publicado: (2015)

Symptomatic hypomagnesemia and proton pump inhibitors
por: Tin, Sim Sai, et al.
Publicado: (2014)

Biomarkers for oralization during long-term proton pump inhibitor therapy predict survival in cirrhosis
por: Horvath, Angela, et al.
Publicado: (2019)

A Proton Pump Inhibitor in the Reformulation Setting: Bioequivalence and Potential Implications for Long‐Term Safety
por: Dubcenco, E, et al.
Publicado: (2017)

The Safety of Long-term Daily Usage of a Proton Pump Inhibitor: A Literature Review
por: Abbas, Mohammed K, et al.
Publicado: (2019)

Long-term use of proton-pump inhibitors: whole-of-population patterns in Australia 2013–2016
por: Daniels, Benjamin, et al.
Publicado: (2020)

When does proton pump inhibitor treatment become long term? A scoping review
por: Haastrup, Peter Fentz, et al.
Publicado: (2021)

Proton pump inhibitor and community pharmacies: Usage profile and factors associated with long-term use
por: de Araújo, Lorena Maria Lima, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_a76j4nmj5pmr3hi4gh4af4fpj5